Evidence map›Paper›PMID 26578821›Full record

ArticleMediators of inflammation2015

Serum Osteocalcin Is Associated with Inflammatory Factors in Metabolic Syndrome: A Population-Based Study in Chinese Males.

Ming Liao, Lirong Huang, Yan Mao, Yonghua Jiang, Ziting Yao, Xinggu Lin, Zheng Lu, Chunlei Wu, Xue Qin, Haiying Zhang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Ming LiaoInstitute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China ; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China ; Guangxi Key Laboratory of Genomic and Personalized Medicine, Nanning, Guangxi 530021, China ; Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, Guangxi 530021, China ; Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19014, USA.
Lirong HuangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China ; Guangxi Key Laboratory of Genomic and Personalized Medicine, Nanning, Guangxi 530021, China ; Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, Guangxi 530021, China.
Yan MaoDepartment of Oncology, Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, China.
Yonghua JiangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China ; Guangxi Key Laboratory of Genomic and Personalized Medicine, Nanning, Guangxi 530021, China ; Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, Guangxi 530021, China.
Ziting YaoCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China ; Guangxi Key Laboratory of Genomic and Personalized Medicine, Nanning, Guangxi 530021, China ; Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, Guangxi 530021, China.
Xinggu LinCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China ; Guangxi Key Laboratory of Genomic and Personalized Medicine, Nanning, Guangxi 530021, China ; Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, Guangxi 530021, China.
Zheng LuInstitute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China ; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China.
Chunlei WuCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China ; Department of Urology, First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan 453100, China.
Xue QinCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China ; Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.
Haiying ZhangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China ; School of Public Health, Guangxi Medical University, Nanning, Guangxi 530021, China ; General Practice School, Guangxi Medical University, Nanning, Guangxi 530021, China.
Zengnan MoInstitute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China ; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China ; Guangxi Key Laboratory of Genomic and Personalized Medicine, Nanning, Guangxi 530021, China ; Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, Guangxi 530021, China.
Guangxi Medical University · CNGuangxi University · CNTumor Hospital of Guangxi Medical University · CNUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteocalcin (OCN) was potentially associated with inflammatory factors, so we explored the metabolic role in this association in general population. Our findings suggest that OCN was positively associated with IgG while inversely associated with C3, both of which were probably mediated by obesity. Moreover, serum OCN was inversely associated with hsCRP in men with impaired fasting glucose, hyperglycemia, or metabolic syndrome, while its association with IgE was significantly observed in men with a normal metabolic profile.

Indexed as

AdultBody Mass IndexComplement C3C-Reactive ProteinHumansImmunoglobulin EImmunoglobulin GMaleMetabolic SyndromeMiddle AgedOsteocalcinComplement C3C-Reactive ProteinImmunoglobulin EImmunoglobulin GOsteocalcin

Identifiers

PMID26578821
PMCPMC4633571
OpenAlexW2169522758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.